PlainRecalls
FDA Drug Low Class III Terminated

Mozobil (plerixafor injection) 24mg/1.2mL (20mg/mL), For Single Use Only, Rx Only, Manufactured by: Genzyme Corporation 500 Kendall Street, Cambridge, MA 02412 USA NDC: 0024-5862-01

Reported: May 17, 2017 Initiated: September 1, 2016 #D-0704-2017

Product Description

Mozobil (plerixafor injection) 24mg/1.2mL (20mg/mL), For Single Use Only, Rx Only, Manufactured by: Genzyme Corporation 500 Kendall Street, Cambridge, MA 02412 USA NDC: 0024-5862-01

Reason for Recall

Labeling: Incorrect or Missing Package Insert

Details

Recalling Firm
Sanofi-Aventis U.S. LLC
Units Affected
2133 vials
Distribution
Nattionwide
Location
Bridgewater, NJ

Frequently Asked Questions

What product was recalled?
Mozobil (plerixafor injection) 24mg/1.2mL (20mg/mL), For Single Use Only, Rx Only, Manufactured by: Genzyme Corporation 500 Kendall Street, Cambridge, MA 02412 USA NDC: 0024-5862-01. Recalled by Sanofi-Aventis U.S. LLC. Units affected: 2133 vials.
Why was this product recalled?
Labeling: Incorrect or Missing Package Insert
Which agency issued this recall?
This recall was issued by the FDA Drug on May 17, 2017. Severity: Low. Recall number: D-0704-2017.